On August 26, 2026 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) reported management participation in four upcoming investor conferences.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Susie Lisa, Senior Vice President of Investor Relations and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 4:30 p.m. EDT.
Susie Lisa and Manisha Pai will also participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 2:10 p.m. EDT.
Reshma Kewalramani, M.D., CEO and President, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026, at 7:00 a.m. EDT.
Susie Lisa and Miroslava Minkova, Executive Director of Investor Relations, will participate in a fireside chat at the Bank of America Global Healthcare Conference London on Wednesday, September 23, 2026, at 10:05 a.m. GMT/5:05 a.m. EDT.

A live webcast of management’s remarks will be available through the Vertex website, www.vrtx.com, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company’s website.

(Press release, Vertex Pharmaceuticals, AUG 26, 2026, View Source [SID1234670356])